CAS 701225-07-2

3-(4-oxo-3(4H)-quinazolinyl)-N-[4-(1-piperidinylsulfonyl)phenyl]propanamide

Description:

3-(4-oxo-3(4H)-quinazolinyl)-N-[4-(1-piperidinylsulfonyl)phenyl]propanamide, with CAS number 701225-07-2, is a synthetic organic compound characterized by its complex structure, which includes a quinazoline moiety and a piperidine sulfonamide group. This compound typically exhibits properties such as moderate to high solubility in organic solvents and potential bioactivity, making it of interest in medicinal chemistry, particularly in the development of pharmaceuticals. The presence of the quinazoline ring suggests potential interactions with biological targets, possibly influencing pathways related to cancer or other diseases. Its sulfonamide group may enhance its pharmacological properties, including improved binding affinity to target proteins. The compound's molecular weight, functional groups, and stereochemistry can significantly affect its reactivity and biological activity. As with many synthetic compounds, its safety profile, including toxicity and environmental impact, would need to be assessed through rigorous testing. Overall, this compound represents a class of molecules that may have therapeutic applications, warranting further investigation into its efficacy and mechanism of action.

Formula: C₂₂H₂₄N₄O₄S

Synonyms:

• 3-(4-oxo-3(4H)-quinazolinyl)-N-[4-(1-piperidinylsulfonyl)phenyl]propanamide
• 3(4H)-Quinazolinepropanamide, 4-oxo-N-[4-(1-piperidinylsulfonyl)phenyl]-
• IRF1-IN-1
• 3-(4-oxoquinazolin-3(4H)-yl)-N-[4-(piperidin-1-ylsulfonyl)phenyl]propanamide

IRF1-IN-1

CAS: 701225-07-2

IRF1-IN-1 (Compound I-2) is an IRF1 inhibitor , inhibiting the cleavage of Caspase 1, GSDMD, IL-1, and PARP1,protecting against skin inflammatory damage.

Formula: C₂₂H₂₄N₄O₄S

Purity: 99.88%

Color and Shape: Solid

Molecular weight: 440.52

Ref: TM-T203129